These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 21496467)
1. Monoclonal antibodies targeting different cell wall antigens of group B streptococcus mediate protection in both Fc-dependent and independent manner. Senn BM; Visram Z; Meinke AL; Neubauer C; Gelbmann D; Sinzinger J; Hanner M; Lundberg U; Boisvert H; Reinscheid D; von Gabain A; Nagy E Vaccine; 2011 May; 29(24):4116-24. PubMed ID: 21496467 [TBL] [Abstract][Full Text] [Related]
2. Immunological fingerprinting of group B streptococci: from circulating human antibodies to protective antigens. Meinke AL; Senn BM; Visram Z; Henics TZ; Minh DB; Schüler W; Neubauer C; Gelbmann D; Noiges B; Sinzinger J; Hanner M; Dewasthaly S; Lundberg U; Hordnes K; Masoud H; Sevelda P; von Gabain A; Nagy E Vaccine; 2010 Oct; 28(43):6997-7008. PubMed ID: 20732466 [TBL] [Abstract][Full Text] [Related]
3. BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood. Santi I; Scarselli M; Mariani M; Pezzicoli A; Masignani V; Taddei A; Grandi G; Telford JL; Soriani M Mol Microbiol; 2007 Feb; 63(3):754-67. PubMed ID: 17212592 [TBL] [Abstract][Full Text] [Related]
4. BibA induces opsonizing antibodies conferring in vivo protection against group B Streptococcus. Santi I; Maione D; Galeotti CL; Grandi G; Telford JL; Soriani M J Infect Dis; 2009 Aug; 200(4):564-70. PubMed ID: 19586417 [TBL] [Abstract][Full Text] [Related]
5. The detection of streptococcal antigens using monoclonal antibodies. Harris MC; Polin RA Clin Lab Med; 1985 Sep; 5(3):545-60. PubMed ID: 3899481 [TBL] [Abstract][Full Text] [Related]
6. Cross-protection between group A and group B streptococci due to cross-reacting surface proteins. Stâlhammar-Carlemalm M; Areschoug T; Larsson C; Lindahl G J Infect Dis; 2000 Jul; 182(1):142-9. PubMed ID: 10882591 [TBL] [Abstract][Full Text] [Related]
7. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models. Givner LB Pediatrics; 1990 Dec; 86(6):955-62. PubMed ID: 2123536 [TBL] [Abstract][Full Text] [Related]
8. Protection against Staphylococcus aureus by antibody to the polyglycerolphosphate backbone of heterologous lipoteichoic acid. Theilacker C; Kropec A; Hammer F; Sava I; Wobser D; Sakinc T; Codée JD; Hogendorf WF; van der Marel GA; Huebner J J Infect Dis; 2012 Apr; 205(7):1076-85. PubMed ID: 22362863 [TBL] [Abstract][Full Text] [Related]
9. Phenotypic variability of X-protein expression by mastitis-causing Streptococcus agalactiae of serotype NT/X and opsonic activities of specific antibodies. Rainard P; Sarradin P; Poutrel B Microb Pathog; 1994 May; 16(5):359-72. PubMed ID: 7815919 [TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview. Fischer GW Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S13-6. PubMed ID: 3041355 [TBL] [Abstract][Full Text] [Related]
11. A new flow-cytometry-based opsonophagocytosis assay for the rapid measurement of functional antibody levels against Group B Streptococcus. Fabbrini M; Sammicheli C; Margarit I; Maione D; Grandi G; Giuliani MM; Mori E; Nuti S J Immunol Methods; 2012 Apr; 378(1-2):11-9. PubMed ID: 22309986 [TBL] [Abstract][Full Text] [Related]
12. Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein. Martin D; Rioux S; Gagnon E; Boyer M; Hamel J; Charland N; Brodeur BR Infect Immun; 2002 Sep; 70(9):4897-901. PubMed ID: 12183534 [TBL] [Abstract][Full Text] [Related]
13. An IgA monoclonal antibody directed against type III antigen on group B streptococci acts as an opsonin. Bohnsack JF; Hawley MM; Pritchard DG; Egan ML; Shigeoka AO; Yang KD; Hill HR J Immunol; 1989 Nov; 143(10):3338-42. PubMed ID: 2681414 [TBL] [Abstract][Full Text] [Related]
14. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. Baker CJ; Rench MA; Edwards MS; Carpenter RJ; Hays BM; Kasper DL N Engl J Med; 1988 Nov; 319(18):1180-5. PubMed ID: 3050524 [TBL] [Abstract][Full Text] [Related]
15. Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum. Lachenauer CS; Baker CJ; Baron MJ; Kasper DL; Gravekamp C; Madoff LC J Infect Dis; 2002 Feb; 185(3):368-74. PubMed ID: 11807719 [TBL] [Abstract][Full Text] [Related]
16. Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci. Baltimore RS; Kasper DL; Baker CJ; Goroff DK J Immunol; 1977 Feb; 118(2):673-8. PubMed ID: 65433 [TBL] [Abstract][Full Text] [Related]
17. Use of the skin protection assay in experimental syphilis to assess protective immunity against a specific Treponema pallidum surface epitope. Blanco DR; Champion CI; Lovett MA FEMS Microbiol Lett; 2005 Aug; 249(1):171-5. PubMed ID: 16000244 [TBL] [Abstract][Full Text] [Related]
18. Conjugate vaccines against group B Streptococcus types IV and VII. Paoletti LC; Kasper DL J Infect Dis; 2002 Jul; 186(1):123-6. PubMed ID: 12089673 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII. Paoletti LC; Pinel J; Johnson KD; Reinap B; Ross RA; Kasper DL J Infect Dis; 1999 Sep; 180(3):892-5. PubMed ID: 10438388 [TBL] [Abstract][Full Text] [Related]
20. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein. Madoff LC; Michel JL; Gong EW; Rodewald AK; Kasper DL Infect Immun; 1992 Dec; 60(12):4989-94. PubMed ID: 1452329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]